Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to $3.3 million.

  • Ocugen's Change in Accured Expenses rose 5219.81% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 381962.62%. This contributed to the annual value of $4.1 million for FY2024, which is 13351.7% up from last year.
  • Latest data reveals that Ocugen reported Change in Accured Expenses of $3.3 million as of Q3 2025, which was up 5219.81% from $2.1 million recorded in Q2 2025.
  • Over the past 5 years, Ocugen's Change in Accured Expenses peaked at $3.9 million during Q3 2022, and registered a low of -$5.0 million during Q1 2023.
  • Its 5-year average for Change in Accured Expenses is $362315.8, with a median of $1.1 million in 2021.
  • In the last 5 years, Ocugen's Change in Accured Expenses surged by 2146000.0% in 2021 and then tumbled by 388931.3% in 2023.
  • Over the past 5 years, Ocugen's Change in Accured Expenses (Quarter) stood at $573000.0 in 2021, then soared by 380.45% to $2.8 million in 2022, then crashed by 170.5% to -$1.9 million in 2023, then surged by 207.62% to $2.1 million in 2024, then skyrocketed by 57.44% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $2.1 million for Q2 2025, and -$3.3 million during Q1 2025.